Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Rockwell Automation (ROK) vs Tenet Healthcare Corporation (THC) Price & Performance

Rockwell AutomationTrade
Tenet Healthcare CorporationTrade

Price performance (Past 24H)

Key statistics

Rockwell Automation vs Tenet Healthcare Corporation — how do they compare? Rockwell Automation trades at $434.15 (market cap $49.07B), while Tenet Healthcare Corporation trades at $260 (market cap $20.92B). The key difference: Rockwell Automation is far larger — about 2.3× Tenet Healthcare Corporation's market cap, and Rockwell Automation pays a 1.25% dividend while Tenet Healthcare Corporation pays none. Which is the better fit depends on your goals — on Pluang, investors hold Rockwell Automation for 74 Days and Tenet Healthcare Corporation for 15 Days on average.

ROKTHC
Market Cap
$49.07B$20.92B
Volume
783,067455,764
Sector
IndustrialsHealth
52-Week High
$495.08$280.77
52-Week Low
$333.75$161.37
Typical Hold Time
74 Days15 Days
Enterprise Value
$52.21B$32.00B
Dividend Yield
1.25%—

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Rockwell Automation

Rockwell Automation (ROK) trades at $434.14, down 3.68% on the day, with a bullish technical signal from moving averages. The company has beaten earnings estimates for the last three quarters, with Q3 2026 results pending. Revenue for 2025 was $8.34 billion, with a net income margin of 13.38%. Recent news highlights its leadership in industrial automation and digital transformation, including partnerships in AI-enabled cyber defense.

The outlook is supported by strong profitability and analyst consensus, but high valuation multiples and competitive pressures pose risks. The consensus price target of $489.89 suggests potential upside, though investors should monitor earnings sustainability and macroeconomic factors affecting industrial demand.

Tenet Healthcare Corporation

Tenet Healthcare (THC) trades at $259.83, up 0.53% with strong technical momentum and bullish moving average signals. The company demonstrates robust fundamentals with consistent earnings beats (Q4 2025-Q2 2026), 82.83% gross margins, and 53.31% ROE. Recent news highlights strong cash flow supporting capital returns, with Q3 2026 results expected October 29, 2026.

THC presents compelling value with a 10.04 P/E ratio and 81.25% analyst buy ratings. Upside potential to $283.36 consensus target exists, though negative cash flow trends and insider selling warrant monitoring. The stock's premium valuation (P/B 4.49) requires sustained execution amid healthcare sector volatility.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

ROK
0% Buy100% Sell
Avg holding period · 74 Days
THC

No sentiment data available yet.

Top news

Latest headlines on both assets

About Rockwell Automation

Rockwell Automation is a pure-play automation competitor that is the successor entity to Rockwell International, which spun off its former Rockwell Collins avionics segment in 2001. As of fiscal 2021, the firm operates through three segments--intelligent devices, software and control, and lifecycle services. Intelligent devices contains its drives, sensors, and industrial components, software and control contains its information and network and security software, while lifecycle services contains its consulting and maintenance services as well as its Sensia JV with Schlumberger.

Read more on ROK →

About Tenet Healthcare Corporation

Tenet Healthcare is a leading diversified healthcare services company that has strategically pivoted toward high-growth ambulatory care. Operating through United Surgical Partners International (USPI), the largest ambulatory platform in the U.S., Tenet manages an expansive network of surgical centers, acute care hospitals, and specialty facilities. The company’s focus on high-acuity services and operational efficiency, supported by its revenue cycle management subsidiary Conifer Health Solutions, positions it as a resilient leader in the evolving U.S. healthcare landscape.

Read more on THC →